Cellular Goods - Commercial launch imminent
Cellular Goods was established in 2018 with the aim of developing premium, research-backed, consumer products, based on biosynthetic cannabinoids. These include skincare products, the first to be formulated with CBG (a rare cannabinoid supplied by Willow Biosciences) following positive studies. Additional partnerships have been formed with leading biosynthetic cannabinoid manufacturers in the United States and Canada. The intention is to launch the first two products under the Cellular Goods brand in the UK before the year end. The company’s website will be the initial distribution channel with other sales partnerships planned.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.